Diese Stelle kennzeichnen: Scam/Spam - abgelaufen - ???search_results.flag.broken??? - Duplikat
800 biomarker discovery and development projects, across more than 100 clinical studies, which generate 20 petabytes and 2 million patient-years of data! All...
Diese Stelle kennzeichnen: Scam/Spam - abgelaufen - ???search_results.flag.broken??? - Duplikat
30 million! That is the estimated number of patients worldwide suffering from inflammatory arthritis. Join Novartis to help find the right drugs that transform ...
Diese Stelle kennzeichnen: Scam/Spam - abgelaufen - ???search_results.flag.broken??? - Duplikat
800 plus biomarker discovery and development projects, across more than 100 clinical studies, which generate 20 petabytes of patient data! All waiting for you...
Diese Stelle kennzeichnen: Scam/Spam - abgelaufen - ???search_results.flag.broken??? - Duplikat
Group Medical Director in Alzheimers disease, Gantenerumab Roche is working to discover and develop transformative medicines for patients with major diseases o...
Diese Stelle kennzeichnen: Scam/Spam - abgelaufen - ???search_results.flag.broken??? - Duplikat
Clinical Virologist We are seeking an exceptional, highly motivated, and talented Clinical Virologist to join our Virology Group. The candidate will join the Im...
Diese Stelle kennzeichnen: Scam/Spam - abgelaufen - ???search_results.flag.broken??? - Duplikat
800 biomarker discovery and development projects, across more than 100 clinical studies, which generate 20 petabytes and 2 million patient-years of data! All...
Diese Stelle kennzeichnen: Scam/Spam - abgelaufen - ???search_results.flag.broken??? - Duplikat
Our client is a pioneer in Drug Discovery and Development. As the world’s largest R&D spender in the pharmaceutical domain, they work in a vast number of drugs...
Diese Stelle kennzeichnen: Scam/Spam - abgelaufen - ???search_results.flag.broken??? - Duplikat
Internship for Scientific Exchange - Identification and validation of novel glial targets for PET tracer discovery - RiSE (Q2 2021, 9 months) At Roche, we...
